Security key
896438504
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB)
CUSIP: 896438504
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Class A Ordinary Shares, $0.0001 par value per share
- Shares outstanding
- 34,586,060,172
- Total 13F shares
- 1,073,075
- Share change
- +223,453
- Total reported value
- $588,883
- Put/Call ratio
- 0%
- Price per share
- $0.54
- Number of holders
- 23
- Value change
- +$107,799
- Number of buys
- 9
- Number of sells
- 11
Report period
Q1 2026
Institutions
23
Top holders
10
TRIB full security history
Previous quarter: Q4 2025
TRINITY BIOTECH PLC SEC filings
TRINITY BIOTECH PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 896438504
Recent filing periods:
Top shareholders of TRIB - TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MiCo IVD Holdings, LLC |
13D/G
|
— |
17%
|
69,450,720
|
$62,505,648 | $0 | 08 Dec 2025 | |
| Novus Diagnostics Ltd. |
13D/G
|
— |
6%
|
1,119,988
|
— | $0 | 23 Dec 2025 | |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0%
|
526,610
|
$417,000 | — | 31 Dec 2025 | |
| Williams & Novak, LLC |
13F
|
Company |
0%
|
93,300
|
$73,800 | — | 31 Dec 2025 | |
| Moss Adams Wealth Advisors LLC |
13F
|
Company |
0%
|
25,666
|
$20,302 | — | 31 Dec 2025 | |
| INSPIRION WEALTH ADVISORS, LLC |
13F
|
Company |
0%
|
25,000
|
$19,775 | — | 31 Dec 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0%
|
22,280
|
$18,000 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
20,319
|
$16,072 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0%
|
20,262
|
$16,027 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0%
|
18,650
|
$14,752 | — | 31 Dec 2025 | |
| BECKER CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
18,000
|
$14,238 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
16,642
|
$13,163 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0%
|
15,797
|
$12,495 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0%
|
14,249
|
$11,271 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0%
|
12,685
|
$10,034 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
6,371
|
$5,038 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
3,804
|
$3,009 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,500
|
$1,975 | — | 31 Dec 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
2,000
|
$1,582 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,095
|
$867 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 31 Dec 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
1,000
|
$791 | — | 31 Dec 2025 | |
| Triumph Capital Management |
13F
|
Company |
0%
|
1,000
|
$791 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
780
|
$617 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
580
|
$459 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
222
|
$176 | — | 31 Dec 2025 | |
| ATWOOD & PALMER INC |
13F
|
Company |
0%
|
20
|
$16 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
11
|
$9 | — | 31 Dec 2025 | |
| CoreCap Advisors, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 | |
| Ronan O'Caoimh |
3/4/5
|
Director |
—
class O/S missing
|
486,208
|
— | — | 18 Mar 2026 | |
| John Gillard |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 18 Mar 2026 |
Institutional Holders of TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) as of Q1 2026
As of 31 Mar 2026,
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,073,075 shares.
The largest 10 holders included
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, Yorkville Advisors Global, LP, Williams & Novak, LLC, Virtu Financial LLC, Moss Adams Wealth Advisors LLC, INSPIRION WEALTH ADVISORS, LLC, Cambridge Investment Research Advisors, Inc., RAYMOND JAMES FINANCIAL INC, BECKER CAPITAL MANAGEMENT INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
27
Q1 2026 holders
23
Holder diff
-4
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.